Wake Forest Baptist Comprehensive Cancer
Winston-Salem, North Carolina, 27157, United States
NCT Number: NCT06881108
This study seeks to develop, test, and revise an intervention designed to address financial hardship (FinFit) among adolescent and young adult (AYA) cancer survivors.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Winston-Salem, North Carolina, 27157, United States
PRIMARY OBJECTIVE:
I. To synthesize CHAT and LIFT to create FinFit, an intervention to address the unique, multilevel determinants of financial hardship among AYAs treated in community oncology practices.
OUTLINE: This is an observational study.
STEP 1: CHAT participants complete an in-depth interview on study.
STEP 2: LIFT participants complete a focus group or an interview on study.
STEP 3: Participants from steps 1 and 2 complete member-checking processes on study.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CHAT is a virtually delivered patient-level intervention designed to improve health insurance and cost-related literacy
LIFT (Lessening the Impact of Financial Toxicity), an intervention developed to coordinate access to existing financial assistance programs.
Based on the findings from Steps 1 and 2, investigators will develop a document that outlines the points of overlap, harmony, or conflict identified by participants.
Time frame: Up to 12 months
Through the analysis of secondary outcomes (CHAT Core Functions - Step 1 LIFT Core Functions - Step 2) to develop, test, and revise an intervention designed to address financial hardship among adolescent and young adults using semi-structured interview data and analysis for the creation of protocol intervention including when, how and to whom the intervention should be delivered to.
Time frame: Up to 12 months
Investigators will use ATLAS.ti, multifunctional qualitative data analysis software, to apply a codebook informed by the Model for Adaptation Design and Impact, and identify themes related to CHAT's core functions. Finally, we will use report-back sessions with interview participants to refine themes.
Time frame: Up to 12 months
Investigators will use ATLAS.ti, multifunctional qualitative data analysis software to apply grounded theory to analyze updates to existing LIFT core functions to apply a codebook informed by the Model for Adaptation Design and Impact, and identify themes related to CHAT's core functions and points of potential overlap, harmony, or conflict with LIFT's and CHAT's core functions using a 90-120 minute focus group to review previously identified core functions.
Time frame: Up to 12 months
Based on the findings from Steps 1 and 2, a document that outlines the points of overlap, harmony, or conflict identified by participants will be developed. Investigators will send this document back to all of the previous participants in a member-checking process, that will occur both virtually and asynchronously, to ensure the document reflects their perspectives. Once this document is finalized, investigators will draft the protocol for FinFit. Once drafted this document will be sent to all previous participants in a member-checking exercise for review and comment to ensure that it reflects their perspectives. The Model for Adaptation Design and Impact (MADI) tool will be used to evaluate potential points of overlap, harmony or conflict between the LIFT and CHAT steps to finally assess for potential influence on implementation outcomes (e.g. feasibility, acceptability) and FinFit outcomes (e.g., financial hardship).
Wake Forest University Health Sciences
Other
Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors: Efficacy and Implementation of a Multilevel Intervention in Community-Based Oncology Practices
Acronym: FinFit Aim 1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07691008
Hematologic Diseases, Hematologic Neoplasms
View Trial DetailsNCT06587100
Hematologic Diseases, Hematologic Neoplasms
San Francisco, California, United States
View Trial DetailsNCT01437787
Hematologic Diseases, Hematologic Neoplasms
Scottsdale, Arizona, United States
View Trial DetailsNCT01420783
Hematologic Diseases, Hematologic Neoplasms
Scottsdale, Arizona, United States
View Trial Details